Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.24
STE's Cash to Debt is ranked higher than
53% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. STE: 0.24 )
STE' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: 0.24

Equity to Asset 0.53
STE's Equity to Asset is ranked higher than
64% of the 301 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. STE: 0.53 )
STE' s 10-Year Equity to Asset Range
Min: 0.43   Max: 0.86
Current: 0.53

0.43
0.86
Interest Coverage 11.02
STE's Interest Coverage is ranked higher than
58% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.80 vs. STE: 11.02 )
STE' s 10-Year Interest Coverage Range
Min: 1.31   Max: 76.18
Current: 11.02

1.31
76.18
F-Score: 5
Z-Score: 4.96
M-Score: -2.64
WACC vs ROIC
9.96%
9.84%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 12.05
STE's Operating margin (%) is ranked higher than
81% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.92 vs. STE: 12.05 )
STE' s 10-Year Operating margin (%) Range
Min: 3.02   Max: 17.1
Current: 12.05

3.02
17.1
Net-margin (%) 7.31
STE's Net-margin (%) is ranked higher than
78% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. STE: 7.31 )
STE' s 10-Year Net-margin (%) Range
Min: -5.2   Max: 10.65
Current: 7.31

-5.2
10.65
ROE (%) 12.62
STE's ROE (%) is ranked higher than
83% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.57 vs. STE: 12.62 )
STE' s 10-Year ROE (%) Range
Min: -10.22   Max: 21.36
Current: 12.62

-10.22
21.36
ROA (%) 6.78
STE's ROA (%) is ranked higher than
82% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. STE: 6.78 )
STE' s 10-Year ROA (%) Range
Min: -5.41   Max: 10.62
Current: 6.78

-5.41
10.62
ROC (Joel Greenblatt) (%) 29.48
STE's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.59 vs. STE: 29.48 )
STE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 4.93   Max: 75.49
Current: 29.48

4.93
75.49
Revenue Growth (3Y)(%) 10.60
STE's Revenue Growth (3Y)(%) is ranked higher than
87% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. STE: 10.60 )
STE' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.6   Max: 13.4
Current: 10.6

0.6
13.4
EBITDA Growth (3Y)(%) 26.60
STE's EBITDA Growth (3Y)(%) is ranked higher than
91% of the 234 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. STE: 26.60 )
STE' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -18.3   Max: 67.8
Current: 26.6

-18.3
67.8
EPS Growth (3Y)(%) 36.70
STE's EPS Growth (3Y)(%) is ranked higher than
93% of the 227 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.20 vs. STE: 36.70 )
STE' s 10-Year EPS Growth (3Y)(%) Range
Min: -72.2   Max: 293.6
Current: 36.7

-72.2
293.6
» STE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

STE Guru Trades in Q1 2014

Joel Greenblatt 16,049 sh (New)
Mario Gabelli 120,000 sh (unchged)
Chuck Royce 1,176,808 sh (unchged)
Jim Simons Sold Out
Vanguard Health Care Fund Sold Out
Ken Fisher 1,611,856 sh (-2.55%)
Paul Tudor Jones 6,900 sh (-28.13%)
» More
Q2 2014

STE Guru Trades in Q2 2014

Jim Simons 31,800 sh (New)
Paul Tudor Jones 15,800 sh (+128.99%)
Joel Greenblatt 17,236 sh (+7.40%)
Chuck Royce 1,159,308 sh (-1.49%)
Ken Fisher 1,586,711 sh (-1.56%)
Mario Gabelli 113,000 sh (-5.83%)
» More
Q3 2014

STE Guru Trades in Q3 2014

RS Investment Management 525,120 sh (New)
Jim Simons 57,600 sh (+81.13%)
Ken Fisher 1,607,171 sh (+1.29%)
Mario Gabelli 113,000 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 1,136,941 sh (-1.93%)
Paul Tudor Jones 11,700 sh (-25.95%)
» More
Q4 2014

STE Guru Trades in Q4 2014

Jeremy Grantham 20,200 sh (New)
Joel Greenblatt 5,127 sh (New)
Paul Tudor Jones 18,500 sh (+58.12%)
RS Investment Management 826,038 sh (+57.30%)
Ken Fisher 1,628,706 sh (+1.34%)
Mario Gabelli 113,000 sh (unchged)
Jim Simons Sold Out
Chuck Royce 987,041 sh (-13.18%)
» More
» Details

Insider Trades

Latest Guru Trades with STE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 31.30
STE's P/E(ttm) is ranked higher than
80% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.70 vs. STE: 31.30 )
STE' s 10-Year P/E(ttm) Range
Min: 11.06   Max: 54.91
Current: 31.3

11.06
54.91
Forward P/E 21.19
STE's Forward P/E is ranked higher than
81% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 163.93 vs. STE: 21.19 )
N/A
PE(NRI) 31.80
STE's PE(NRI) is ranked higher than
83% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.30 vs. STE: 31.80 )
STE' s 10-Year PE(NRI) Range
Min: 11.08   Max: 54.83
Current: 31.8

11.08
54.83
P/B 3.90
STE's P/B is ranked higher than
61% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.96 vs. STE: 3.90 )
STE' s 10-Year P/B Range
Min: 1.68   Max: 3.91
Current: 3.9

1.68
3.91
P/S 2.28
STE's P/S is ranked higher than
70% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.29 vs. STE: 2.28 )
STE' s 10-Year P/S Range
Min: 0.94   Max: 2.33
Current: 2.28

0.94
2.33
PFCF 26.80
STE's PFCF is ranked higher than
84% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 108.70 vs. STE: 26.80 )
STE' s 10-Year PFCF Range
Min: 8.72   Max: 114.75
Current: 26.8

8.72
114.75
POCF 18.09
STE's POCF is ranked higher than
83% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.76 vs. STE: 18.09 )
STE' s 10-Year POCF Range
Min: 7.09   Max: 22.12
Current: 18.09

7.09
22.12
EV-to-EBIT 21.17
STE's EV-to-EBIT is ranked higher than
84% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.92 vs. STE: 21.17 )
STE' s 10-Year EV-to-EBIT Range
Min: 7.2   Max: 29
Current: 21.17

7.2
29
PEG 4.97
STE's PEG is ranked higher than
87% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. STE: 4.97 )
STE' s 10-Year PEG Range
Min: 0.53   Max: 22.76
Current: 4.97

0.53
22.76
Shiller P/E 32.80
STE's Shiller P/E is ranked higher than
86% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. STE: 32.80 )
STE' s 10-Year Shiller P/E Range
Min: 14.83   Max: 34.83
Current: 32.8

14.83
34.83
Current Ratio 2.75
STE's Current Ratio is ranked higher than
74% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. STE: 2.75 )
STE' s 10-Year Current Ratio Range
Min: 1.49   Max: 5.39
Current: 2.75

1.49
5.39
Quick Ratio 2.00
STE's Quick Ratio is ranked higher than
77% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. STE: 2.00 )
STE' s 10-Year Quick Ratio Range
Min: 1.18   Max: 4.85
Current: 2

1.18
4.85
Days Inventory 58.95
STE's Days Inventory is ranked higher than
93% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 135.02 vs. STE: 58.95 )
STE' s 10-Year Days Inventory Range
Min: 54.45   Max: 93.17
Current: 58.95

54.45
93.17
Days Sales Outstanding 59.77
STE's Days Sales Outstanding is ranked higher than
78% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 70.75 vs. STE: 59.77 )
STE' s 10-Year Days Sales Outstanding Range
Min: 62.38   Max: 105.39
Current: 59.77

62.38
105.39

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.30
STE's Dividend Yield is ranked higher than
56% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.22 vs. STE: 1.30 )
STE' s 10-Year Dividend Yield Range
Min: 0.15   Max: 2.34
Current: 1.3

0.15
2.34
Dividend Payout 0.40
STE's Dividend Payout is ranked higher than
84% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. STE: 0.40 )
STE' s 10-Year Dividend Payout Range
Min: 0.1   Max: 0.51
Current: 0.4

0.1
0.51
Dividend growth (3y) 13.60
STE's Dividend growth (3y) is ranked higher than
83% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. STE: 13.60 )
STE' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 34.7
Current: 13.6

0
34.7
Yield on cost (5-Year) 3.41
STE's Yield on cost (5-Year) is ranked higher than
79% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.58 vs. STE: 3.41 )
STE' s 10-Year Yield on cost (5-Year) Range
Min: 0.39   Max: 6.14
Current: 3.41

0.39
6.14
Share Buyback Rate 0.20
STE's Share Buyback Rate is ranked higher than
89% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -1.70 vs. STE: 0.20 )
STE' s 10-Year Share Buyback Rate Range
Min: 4.8   Max: -2.5
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 19.30
STE's Price/Tangible Book is ranked lower than
52% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.60 vs. STE: 19.30 )
STE' s 10-Year Price/Tangible Book Range
Min: 2.69   Max: 18.32
Current: 19.3

2.69
18.32
Price/DCF (Projected) 1.90
STE's Price/DCF (Projected) is ranked higher than
82% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.90 vs. STE: 1.90 )
STE' s 10-Year Price/DCF (Projected) Range
Min: 0.82   Max: 14.78
Current: 1.9

0.82
14.78
Price/Median PS Value 1.50
STE's Price/Median PS Value is ranked higher than
63% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. STE: 1.50 )
STE' s 10-Year Price/Median PS Value Range
Min: 0.55   Max: 2.83
Current: 1.5

0.55
2.83
Price/Peter Lynch Fair Value 2.10
STE's Price/Peter Lynch Fair Value is ranked higher than
93% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. STE: 2.10 )
STE' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.45   Max: 41.83
Current: 2.1

0.45
41.83
Price/Graham Number 5.20
STE's Price/Graham Number is ranked higher than
74% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. STE: 5.20 )
STE' s 10-Year Price/Graham Number Range
Min: 1.17   Max: 11.56
Current: 5.2

1.17
11.56
Earnings Yield (Greenblatt) 4.70
STE's Earnings Yield (Greenblatt) is ranked higher than
80% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. STE: 4.70 )
STE' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.4   Max: 13.9
Current: 4.7

3.4
13.9
Forward Rate of Return (Yacktman) 17.36
STE's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.67 vs. STE: 17.36 )
STE' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 6.2   Max: 39.2
Current: 17.36

6.2
39.2

Analyst Estimate

Mar15 Mar16
Revenue(Mil) 1,870 2,001
EPS($) 2.92 3.26
EPS without NRI($) 2.92 3.26

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:STQ.Germany,
Steris Corp was founded as Innovative Medical Technologies in Ohio in 1985, and renamed STERIS Corporation in 1987. The Company is a provider of infection prevention and other procedural products and services, focused mainly on healthcare, pharmaceutical and research. It offers a mix of capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room ('OR') integration; consumable products, such as detergents and skin care products, gastrointestinal ('GI') endoscopy accessories, and other products; services, including equipment installation and maintenance; and microbial reduction of medical devices, instrument and scope repair solutions, and laboratory testing services. The Company operates in three business segments: Healthcare, Life Sciences, and STERIS Isomedix Services. 'Corporate and other,' which is presented separately, contains the Defense and Industrial business unit plus costs that, are associated with being a publicly traded Company and certain other corporate costs. The Company's Healthcare segment manufactures and sells capital equipment, accessory, consumable, and service solutions to healthcare providers, including acute care hospitals, and surgery and gastrointestinal centers. Brand names for these products include, SYSTEM 1E, Amsco, Hamo, Reliance, Cmax, Harmony, Kindest Kare, Alcare, Verify, Cal Stat, and Roth Net. Its Life Sciences segment manufactures and sells engineered capital equipment, formulated cleaning chemistries, and service solutions to pharmaceutical companies, and private and public research facilities around the globe. Brand names for these products include Amsco, Reliance, Finn-Aqua, VHP, and the CIP Products. Its Isomedix segment operates through a network of facilities located in North America. It sells an array of materials processing services using gamma irradiation, and ethylene oxide ('EO') technologies. It provides microbial reduction services based on Customer specifications to companies that supply products to the healthcare, industrial, and consumer products industries. Its competitors include Belimed, Ecolab, Fedegari, Getinge, MECO, Stilmas, Techniplast, Sterigenics International, Inc. The Company is subject to various laws and governmental regulations concerning environmental matters and employee safety and health in the United States and in other countries.
» More Articles for STE

Headlines

Articles On GuruFocus.com
16 Best Dividend Paying Healthcare Stocks Sep 03 2012 
Supply Your Portfolio with Healthy Growth from Medical Suppliers May 25 2012 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2011 
STERIS Corp. Reports Operating Results (10-Q) Nov 09 2010 
STERIS Corp. (STE) President & CEO Walter M Jr Rosebrough sells 11,600 Shares Oct 02 2010 
STERIS Corp. (STE) SVP & CFO Michael J Tokich sells 9,000 Shares Apr 09 2010 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2010 
Robert Olstein on Hedge Fund regulations. Recent Olstein buys. Jan 15 2010 
STERIS Corp. Reports Operating Results (10-Q) Nov 03 2009 
STERIS Corp. (STE) President & CEO Walter M Jr Rosebrough sells 5,000 Shares Oct 02 2009 


More From Other Websites
Form 8.3 - Steris Corporation Apr 17 2015
Form 8.3 - Steris Corporation Apr 16 2015
STERIS Corporation to Host Conference Call to Discuss Fiscal 2015 Fourth Quarter and Full Year... Apr 15 2015
STERIS Corporation to Host Conference Call to Discuss Fiscal 2015 Fourth Quarter and Full Year... Apr 15 2015
Will STERIS' Synergy Health Deal Facilitate Growth Further? - Analyst Blog Apr 15 2015
Form 8.3 - Steris Corporation Apr 14 2015
Form 8.3 - Steris Corporation Apr 02 2015
STERIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Apr 02 2015
How to Play the Healthcare Rally Apr 01 2015
Form 8.3 - Steris Corporation Mar 31 2015
Form 8.3 - Steris Corporation Mar 27 2015
Form 8.3 - Steris Corporation Mar 26 2015
Form 8.3 - Steris Corporation Mar 25 2015
Form 8.3 - Steris Corporation Mar 24 2015
Form 8.3 - Steris Corporation Mar 23 2015
Form 8.3 - Steris Corporation Mar 20 2015
Form 8.3 - Steris Corporation Mar 19 2015
Form 8.3 - Steris Corporation Mar 18 2015
Form 8.3 - Steris Corporation Mar 17 2015
Form 8.3 - Steris Corporation Mar 16 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK